Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

por Thum, Thomas, Springer, Jochen
Publicado 2011

Evidence for an effect of ACE inhibitors on cancer cachexia

por Schanze, Nancy, Springer, Jochen
Publicado 2012

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancie...

por Tschirner, Anika, Springer, Jochen
Publicado 2012

MicroRNAs in muscle wasting

por Suzuki, Tsuyoshi, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2019)

Biomarkers for cancer cachexia: where do we stand?

por Palus, Sandra, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2020)

Physical activity for the prevention and treatment of sarcopenic obesity

por Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2017)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?

por Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?

por Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass

por Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2017)

Skeletal muscle wasting in chronic heart failure

por Suzuki, Tsuyoshi, Palus, Sandra, Springer, Jochen
Publicado en ESC Heart Fail (2018)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

por Lena, Alessia, Anker, Markus S., Springer, Jochen
Publicado en Int J Mol Sci (2020)

Muscle wasting: an overview of recent developments in basic research

por Palus, Sandra, von Haehling, Stephan, Springer, Jochen
Publicado 2014

Blocking myostatin: muscle mass equals muscle strength?

por Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2020)

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

por Drescher, Cathleen, Konishi, Masaaki, Ebner, Nicole, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2015)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in...

por Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2015)

Concern regarding quality and quality of muscle

por Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia

por Konishi, Masaaki, Ishida, Junichi, Saito, Masakazu, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients

por Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients

por Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle

por Konishi, Masaaki, Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Publicado en J Cachexia Sarcopenia Muscle (2016)